![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 34736-34742, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, May 30, 2002, and in revised form, July 12, 2002
The accessory gene regulator (agr) of
Staphylococcus aureus is the central regulatory system that
controls the gene expression for a large set of virulence factors. This
global regulatory locus consists of two transcripts: RNAII and RNAIII.
RNAII encodes four genes (agrA, B,
C, and D) whose gene products assemble a quorum sensing system. RNAIII is the effector of the Agr response. Both the
agrB and agrD genes are essential for the
production of the autoinducing peptide, which functions as a signal for
the quorum sensing system. In this study, we demonstrated the
transmembrane nature of AgrB protein in S. aureus. A
transmembrane topology model of AgrB was proposed based on AgrB-PhoA
fusion analyses in Escherichia coli. Two hydrophilic
regions with several highly conserved positively charged amino acid
residues among various AgrBs were found to be located in the
cytoplasmic membrane as suggested by PhoA-AgrB fusion studies. However,
this finding is inconsistent with the putative transmembrane profile of
AgrB by computer analysis. Furthermore, we detected an intermediate
peptide of processed AgrD from S. aureus cells
expressing AgrB and a 6 histidine-tagged AgrD. These results provide
direct evidence that AgrB is involved in the proteolytic processing of
AgrD. We speculate that AgrB is a novel protein with proteolytic enzyme
activity and a transporter facilitating the export of the processed
AgrD peptide.
Staphylococcus aureus is an important bacterial
pathogen that causes a great variety of human diseases. The
pathogenicity of S. aureus largely depends on a set of
virulence factors. These include cell wall-associated proteins involved
in attaching the bacteria to host cells or extracellular matrices and
protecting the bacteria against host defenses. Other factors are
secreted proteins that attack host cells, degrade components of
extracellular matrices, and interfere with immune responses (1). The
expression of these virulence factor genes is primarily regulated by a
quorum sensing system encoded by the global regulatory locus, the
accessory gene regulator (agr). At low cell density, the
agr genes are continuously expressed at basal levels. A
signal molecule, autoinducing peptide (AIP),1 produced and secreted
by the bacteria, accumulates outside of the cells (2, 3). When the cell
density increases and the AIP concentration reaches a threshold, it
activates the agr response (2), i.e. activation
of secreted protein gene expression and subsequent repression of cell
wall-associated protein genes (1, 4-6).
The agr locus consists of two operons, P2 and P3 (6-7). The
P3 transcript, RNA III, the effector of the agr response,
functions as the regulator controlling the expression of virulence
factor genes by a yet to be defined mechanism (6, 8-12). The P2
transcript, RNA II, encodes four genes, agrA, B,
C, and D (6, 7). AgrC, a transmembrane protein,
is a sensor kinase of the classic bacterial two component signal
transduction system: the N-terminal half is the input domain that
interacts with a signal molecule produced by the bacteria, and the
C-terminal half is a transmitter that is autophosphorylated at a
conserved histidine upon stimulation by the signal molecule (2, 13,
14). AgrA resembles a response regulator, which is required for the
activation of both agr promoters P2 and P3 (2, 7, 15),
although it is not clear whether AgrA binds to these two promoters
directly (16, 17). It is possible that either phosphorylated AgrA would
bind to the agr promoters or AgrA would interact with
another global regulator, SarA, to control the agr
expression (17-19).
Both agrB and agrD genes are essential for the
production of the signal molecule, AIP (2, 3). The AgrD propeptide is ribosomally synthesized and subsequently processed and secreted from
the bacteria (2, 3, 20). The AIP is a thiolactone molecule containing a
ring of 5 amino acids formed by a thioester linkage between the
sulfhydryl group of a cysteine residue and the C-terminal carboxyl
group, and a tail ranging from 2 to 4 amino acid residues depending on
staphylococcal species and groups within the same species (3, 21-23).
This thioester bond is critical for its agr activation
activity (14, 21, 22, 24). AgrB is predicted to be a transmembrane
protein (7), and the association of Staphylococcus
epidermidis AgrB with the cell membrane has been
demonstrated recently (25). AgrB is absolutely required for the
production of AIP (2, 3). Because the production of mature AIP involves
several steps, including proteolytic digestion, thioester bond
formation, and secretion, we reasoned that AgrB was probably the
protein to carry out all these processes. In this study, we confirmed
the membrane localization and proposed the transmembrane topology of
S. aureus AgrB. Further more, we provided direct evidence
showing that AgrB was involved in the proteolytic processing of AgrD.
Bacterial Strains and Growth Conditions--
S.
aureus strains and plasmids used in this study are listed in Table
I. S. aureus cells were grown
in CY-GP broth (26), supplemented with antibiotics (chloramphenicol, 5 µg/ml, erythromycin, 5 µg/ml) when necessary. Bacteria grown
overnight at 37 °C on GL plates (26) were routinely used to
inoculate liquid cultures. Growth of cells was monitored with either a
Klett-Summerson colorimeter with a green (540 nm) filter (Klett, Long
Island City, NY) or a VERSAmax microplate reader (Molecular Devices) at
OD650 nm. Expression of genes driven by staphylococcal
S. aureus Plasmid Construction--
All S. aureus
plasmids used in this study were based on either pRN5548 or pRN6441 (7)
(see Table I). pGJ2001 was constructed by digesting pRN6912 (2) with
SphI and SalI, blunting with DNA polymerase I
large fragment (Klenow), and re-ligating. A ClaI DNA
fragment from pGJ2001 containing agrB gene under the control of the staphylococcal PblaZ was inserted into the
ClaI site of pRN6441 to give rise to pLZ2003. To construct
the C-terminal His6-tagged AgrB (AgrB-6xHis)
expression plasmid pLZ2004, a PCR product with oligonucleotides GJ#14:
5'-GCTCTAGATCGTATAATGACAG-3' (XbaI underlined)
and GJ#27 5'-CTAATGATGATGATGATGATGTTTTAAGTCCTCCTTAATAAAG-3' (6 histidine codons and a stop codon underlined) as primers, and pGJ2001 as the template was generated. The PCR product was digested with XbaI and cloned into the XbaI and
EcoRI (blunted with Klenow) sites of pRN5548. pGJ4002 was
constructed by cloning a ClaI DNA fragment containing the
agrD gene under the control of the PblaZ promoter
from pRN6913 (2) into pRN6441. pGJ4004 was constructed as follows: a
PCR product using oligonucleotides GJ#12
5'-ATGAATTCTGAATACATTATTTAACTTATTTTTTG-3' (5'of
agrD, italic, with an added EcoRI site,
underlined) and GJ#13 5'-ATGTAATATGATTAAGGACGC-3' (within
agrC gene) as primers and pRN6911 (2) as the template was
prepared, cut with EcoRI, and inserted into the
EcoRI and HindIII (blunted with Klenow) sites of
pRSET-A (Invitrogen), resulting plasmid pRSET-A-agrD. A
second PCR product containing AIP Activity Assay--
AIP activity was assayed according to
the method described previously (2) except that S. aureus cells expressing AgrD and AgrB or
His6-tagged AgrD and AgrB under the control of the
staphylococcal PblaZ promoter were induced with methicillin
(0.5 µg/ml) at 37 °C for 5 h.
Construction of agrB-phoA Fusions and Alkaline Phosphatase
Activity Assay--
PCR products using the forward primer GJ#71
5'-GAAGATCTTTGAATTATTTTGATAATAAAATT-3' (5'
agrB in italic, BglII site underlined) and the
reverse primers (with an added BamHI site) within
agrB gene, and pGJ2001 plasmid DNA as the template were
prepared, digested with BglII and BamHI, and
ligated into the BglII site of the E. coli
phoA fusion vector pAWLP-2 or pAWLP-3 (kindly provided by Dr.
Andrew Wright, Tuft's University School of Medicine). The resulting
plasmids were transformed into E. coli MC1061.
The junction between agrB and phoA and the
agrB region of each construct was verified by DNA
sequencing. PhoA (alkaline phosphatase) activity was measured using
overnight cell cultures in LB broth. The colorimetric reaction product
was measured using Sigma 104 phosphatase substrate (Sigma) as described
previously (29).
Cell Fractionation--
S. aureus cells were grown in
CYGP broth and induced with 0.5 µg/ml methicillin at 37 °C for
3 h. After harvesting, the cell pellet was suspended in 1×
sucrose-sodium maleate-MgCl2 (26) containing 10 µg/ml
lysostaphin and incubated for 30 min at 37 °C. The protoplasts were
then collected and lysed by addition of 1× phosphate-buffered saline
supplemented with 1 mg/ml lysozyme and 1 mM
phenylmethanesulfonyl fluoride and incubated on ice for 30 min. The
cell lysate was briefly sonicated, and the unlysed cells were removed
by centrifugation at 7,000 × g for 10 min at 4 °C.
The cell lysate was then centrifuged at 200,000 × g
for 2 h at 4 °C to separate the cell membrane and cytoplasmic
fractions. The membrane pellet was washed three times with ice-cold
water, resuspended in water, and stored at Purification of His6-tagged
Proteins--
His6-tagged proteins were purified with
nickel-nitrilotriacetic acid-agarose under denaturing conditions (in
the presence of 8 M urea) according to the manufacturer's
instructions (Qiagen). 1× SDS sample buffer was directly added to the
His6-tagged protein bound beads to elute the purified protein.
Western Blotting--
Whole cell lysate, membrane, cytoplasmic
fraction, or purified His6-tagged protein samples were
boiled for 5 min in 1× SDS sample buffer. Proteins were separated
either by Tris-glycine SDS-PAGE (27) (for AgrB-6xHis and AgrB-PhoA
fusion proteins) or by Tris-Tricine SDS-PAGE (30) (for AgrD-HDH
protein). The separated proteins were then electrophoretically
transferred to PROTRAN nitrocellulose membranes (Schleicher & Schuell).
After blocking overnight at 4 °C with TBS buffer (27) plus Tween 20 (0.05%) containing 5% nonfat milk, the membranes were incubated in
the blocking buffer with the primary antibody (1:500 dilution of mouse
anti-pentaHis monoclonal antibody, Qiagen; 1:1000 dilution of rabbit
polyclonal anti-E. coli PhoA antibody, kindly
provided by Dr. Andrew Wright, Tufts University School of Medicine;
1:5000 dilution of anti-T7-tag monoclonal antibody, Novagen) for 1 h at room temperature. The blots were washed extensively and probed with horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit secondary antibody (Amersham Biosciences). The immunoblots were detected with the SuperSignal West Pico Chemiluminescent detection kit
(Pierce) followed by exposure to X-Omat film (Kodak).
S. aureus AgrB Is Located in the Cytoplasmic Membrane--
To
directly detect and purify the AgrB protein from S. aureus, we made a construct (pLZ2004) in which 6 histidine
codons were added to the 3'-end of RN6390B agrB gene. This
plasmid, or the cloning vector pRN5548, was transformed into an
agr-null S. aureus strain GJ2035, creating
strains LZ2004 and LZ0001, respectively. Western blot hybridization
analysis with an anti-pentaHis monoclonal antibody as a probe revealed
a band with an estimated size of about 23 kDa from whole cell lysate of
LZ2004 expressing the His6-tagged AgrB (data not shown).
This band was not observed from LZ2001 cell lysate (data not shown).
The size of the protein detected was consistent with that of the
predicted molecular weight of the His6-tagged AgrB. This
result suggests that the AgrB-6xHis protein was expressed in S. aureus. The effect of the 6 histidine residues on the AgrB
processing of AgrD was determined as follows. Conditioned media were
prepared from cells expressing only wild-type AgrD (LZ4200) or both
wild-type AgrB and wild-type AgrD (LZ4201). In parallel, conditioned
media were prepared from cells expressing the His6-tagged
AgrB and wild-type AgrD (LZ4202). The AIP activities in the conditioned
media were measured. LZ4202 produced comparable AIP activity with that
of strain LZ4201 (data not shown), indicating that the C-terminal
His6-tagged AgrB functioned normally in S. aureus.
To determine the cellular localization of the AgrB protein in S. aureus, cytoplasmic and membrane fractions were prepared by
ultracentrifugation from LZ0001 or LZ2004 strains. Western blot
hybridization with anti-pentaHis monoclonal antibody as a probe showed
that the 23-kDa band as detected in the whole cell lysate of LZ2004
appeared in the membrane fraction of the same strain (data not shown).
To confirm this result, affinity chromatography with
nickel-nitrilotriacetic acid-agarose was employed to
partially purify proteins under denaturing conditions from the
cytoplasmic and membrane fractions of LZ0001 or LZ2004 cells. This
method provides about five times more concentrated proteins. Again,
Western blot hybridization analysis showed the 23-kDa protein presented only in the membrane fraction from cells expressing the
His6-tagged AgrB (data not shown). These results,
consistent with a previous report on the S. epidermidis AgrB
(25), confirmed that AgrB is located in the cytoplasmic membrane.
Transmembrane Topology of AgrB by PhoA Fusions--
To facilitate
our experimental design in constructing AgrB-PhoA fusions, hydropathy
profiles of AgrB proteins from the four groups of S. aureus
(3, 23) as well as the AgrB homologs from S. epidermidis
(21) and Staphylococcus lugdunensis (31) were
analyzed. A Kyte-Doolittle (32) hydrophobicity plot for these AgrB
proteins is shown below in Fig. 2A. The AgrB proteins were
also analyzed with various programs available through the Internet.
These programs include TopPred 2 (33)
(bioweb.pasteur.fr/seqanal/interfaces/toppred.html), TMHMM (34)
(www.cbs.dtu.dk/services/TMHMM-2.0/), and Dense Alignment Surface
method (DAS) (35) (www.sbc.su.se/~miklos/DAS/). Despite the highly
variable sequences among the AgrBs, all programs gave similar results
in hydrophobicity plots, although the predicted transmembrane
To confirm the topology predicted from the hydrophobicity analyses,
various lengths of the 5' region or the full-length of the
agrB gene from RN6390B were prepared by PCR and then
inserted into the E. coli phoA fusion plasmid
pAWLP-2 or pAWLP-3 creating a series of agrB-phoA
fusion plasmids. A total of 23 such fusion plasmids were generated. The
expression of the fusion proteins in E. coli
MC1061 carrying the agrB-phoA fusion plasmid was
evaluated by Western blot hybridization of whole cell lysates with a
rabbit anti-E. coli PhoA polyclonal antibody.
Proteins corresponding to the molecular weight of all the fusion
proteins were identifiable, however, high numbers of nonspecific bands
also appeared due to the cross-reaction of the polyclonal antibody with
other proteins (data not shown). To eliminate the background problem,
Triton X-100-insoluble fractions prepared from whole cell lysates were used for Western blot analysis. This non-ionic detergent could dissolve
most of the membrane proteins but not all of them, especially when the
proteins are highly expressed as in these experiments in which the
fusion proteins are expressed under the control of a constitutive
Pbla promoter on a high copy number plasmid. A similar method
was used by Saenz et al. (25) to detect S. epidermidis AgrB. As shown in Fig.
1A, all the AgrB-PhoA fusion proteins with the correct molecular weights were detected. The amounts
of the fusion proteins expressed in each strain were comparable, although in a few cases there were different amounts of degradation products. A protein band with an approximate molecular mass of 55 kDa was present in samples, including the controls, suggesting that
it might be a nonspecific band or endogenous PhoA protein.
The alkaline phosphatase (PhoA) activity of each strain expressing the
AgrB-PhoA fusion protein was measured (Fig. 1B). The location of the fusion point of each fusion protein was then assigned based on the PhoA activity. PhoA-positive suggests that the PhoA portion, thus the fusion point of the protein, is in the periplasm of
E. coli, whereas PhoA-negative indicates that the fusion
point is either in the membrane or in the cytoplasm. The fusions
Gln-10, Asn-19, Gln-28, and Ala-37 failed to show any PhoA activity,
suggesting that the N-terminal portion of AgrB, a highly hydrophilic
region, was in the cytoplasm. We note that AgrB does not seem to have a
signal peptide at its N-terminal portion, because deletion mutation of
AgrB from amino acid residues 2 to 34 had no effect on the integration
of AgrB into S. aureus
membrane.2 The full-length
AgrB-PhoA fusion (Lys-189) had no PhoA activity, indicating that the C
terminus of AgrB is also in the cytoplasm. The transmembrane segments
I, II, IV, and V predicted from the computer analysis (Fig.
2A) were partially confirmed
based on the PhoA activity of Ala-37 and Thr-62, Ser-88 and Pro-96,
Arg-140 and Pro-162, and Ala-175 and Lys-189 fusions. However, both
Ile-104 and Ser-116 fusions predicted to be in the transmembrane
segment III had PhoA activities. Considering that both fusions Pro-96 and Thr-128 were also PhoA active, this flanking region was probably located outside of the cytoplasmic membrane. Fusions Arg-71, Ala-76, Ala-78, Pro-79, and Ser-88 and fusions Ile-133, Arg-136, Leu-137, and
Arg-140 all lacked PhoA activity, suggesting these amino acid residues
were either in the transmembrane segments or in the cytoplasm. Since
both the N terminus and the C terminus were positioned in the
cytoplasm, it was reasonable to assign the regions from Thr-65 to
Ala-76 and from Ala-126 to Ile-138 as transmembrane segments. Based on
these AgrB-PhoA fusion results and computer analyses, a putative AgrB
transmembrane topology model was proposed, as shown in Fig.
2B. In this model, the AgrB protein contains six transmembrane segments. Two segments consist of highly hydrophilic amino acid residues and a relatively highly hydrophobic loop positions outside of the membrane.
AgrB Is Involved in the Proteolytic Processing of AgrD--
We
previously showed that the agrB gene is required for the
production of the mature AIP in staphylococci (2-3), however, no
direct evidence showing the involvement of AgrB in the proteolytic processing of AgrD has been reported. To study the role of AgrB in this
process, we made a construct (pLZ4005) in which 6 histidine codons were
added to the 3'-end of RN6390B agrD gene and a DNA fragment
containing His6 as well as a T7 epitope coding region was
added at the 5'-end. A diagram of the double-tagged AgrD (AgrD-HDH) fusion protein is shown in Fig.
3A. S. aureus LZ2403 expressing both RN6390B AgrB and AgrD-HDH
produced mature AIP, although the mature AIP activity was lower than
that of GJ2404 expressing the wild-type AgrB and AgrD (Fig.
3B), indicating the AgrD-HDH fusion protein was functional.
Western blot hybridization with anti-pentaHis monoclonal antibody was
performed using whole cell lysates from cells expressing AgrD-HDH with
or without AgrB. As seen in Fig. 3C, a specific pentaHis
antibody-reactive band of ~12 kDa in size, corresponding to the
predicted molecular weight of AgrD-HDH, was present from cells
expressing AgrD-HDH (LZ4005, LZ0403, and LZ2403) (Fig. 3C,
lanes 2-4) but not from cells not expressing AgrD-HDH (LZ0001) (Fig. 3C, lane 1). An additional protein
band with an approximate molecular mass of 9 kDa appeared from LZ2403
cells expressing both AgrB and AgrD-HDH (Fig. 3C, lane
4). This same protein band was also detected in the Western blot
with LZ2403 cell lysate and anti-T7 tag monoclonal antibody as a probe
(Fig. 3D, lane 4). These results indicate that
the 9-kDa protein was an AgrD-HDH-processing product consisting of the
His6-T7 tag and the N-terminal part of AgrD and that AgrB
was required for the production of this AgrD-processing product.
However, it was not clear whether the 9-kDa protein was an
AgrD-HDH-processing intermediate (Fig. 3A, fragment
A) or a final product (Fig. 3A, fragment C) or whether AgrB alone or AgrB together with other protein(s) carried out this proteolytic reaction. As noted in lane 4 of Fig. 3
(C and D), another weak band of about 7 kDa in
size was present in both blots. This protein was larger than the
His6-T7 tag (fragment E, 5807 Da) but smaller
than fragment C (8477 Da), suggesting that this protein was
a degradation product of the 9-kDa protein and the cleavage site was
within the N-terminal part of AgrD.
Because the agr system coordinately regulates the
expression of a series of virulence factors, cross inhibition of the
agr gene expression among different species or groups of the
same species of staphylococci by AIP may have great clinical
significance in controlling the pathogenicity (3-5, 20). Although
significant advances have been made on the structure and activity of
the AIPs (14, 22, 24, 36), it remains unclear how AgrD is processed in vivo to form the active mature AIP. Our previous research
showed that agrB encodes a protein required for the
processing of the AgrD propeptide, and despite the sequence divergence
of AgrB and AgrD, both retain the specific interactions required for
maturation of the peptide derivatives of AgrD (2-4).
In this study, we expressed His6-tagged AgrB in S. aureus and confirmed that AgrB is anchored in the cytoplasmic
membrane. These results are consistent with a previous report on the
AgrB homolog from S. epidermidis (25). AgrD is processed in
a complicated way; it involves proteolytic digestion of the propeptide
at two sites, further modification by the formation of a thioester
linkage, and secretion into the surrounding environment (2-3, 22). In addition, the fact that AgrB is required for the production of the
mature AIP molecule, which accumulates outside of the cells, makes it
plausible to hypothesize that AgrB may be involved in all these
processes. Therefore, the understanding of the secondary structure of
AgrB is critical to elucidate the mechanism of the AgrD processing by
the AgrB protein and to facilitate the identification of domains that
play important roles in the AgrD processing.
The AgrB membrane topology we proposed in this report was based on the
PhoA fusion analyses in E. coli in conjunction
with computerized hydrophobicity analysis. Such a PhoA fusion analysis method has been successfully used in many transmembrane topology studies such as the membrane topology of LcnC, a protein involved in
both maturation and exporting of lactococcin (37), and various S. aureus membrane proteins (13, 38-39).
PhoA fusion results confirmed that four of the five hydrophobic domains
were transmembrane helices as predicted by computer analysis. The
hydrophobic region between residue Ile-104 and Ala-124 was assigned as
an outside loop based on the PhoA activities of Pro-96, Ile-104,
Ser-116, and Thr-128. However, Ser-116 had an intermediate level of
alkaline phosphatase activity, suggesting that this hydrophobic region
of the AgrB protein was not clearly periplasmic but was in some
intermediate zone, i.e. a small region around residue 116 could be in a transition state between the outer surface and the
membrane. Thus this region of AgrB might play an important role in the
secretion of AIP or in the processing of the AgrD propeptide and
secretion of AIP. PhoA fusions Arg-71, Ala-76, Ala-78, Pro-79, Ser-88,
Ile-133, Arg-136, Leu-137, and Arg-140 all lacked alkaline phosphatase
activity, although these fusion points were located in two highly
hydrophilic regions. There were three possible ways to position these
two regions. First, they are periplasmic. It has been reported that a
PhoA fusion to a known periplasmic domain may have low alkaline
phosphatase activity because of the presence of a positively charged
residue in the membrane-spanning segment to the N-terminal side (40). However, this would not explain our results, because both areas are
preceded by fusion points that are PhoA-active. Second, they are in the
cytoplasm. But the confirmation of the four computer-predicted transmembrane segments by our PhoA fusion analyses made this
possibility less likely. Finally, they are transmembrane segments. The
hydrophobicity is not a necessity for the formation of a transmembrane
segment. As reported by Ota et al. (41), an internal
signal-anchor sequence with Nexo/Ccyt topology
is able to locate a preceding hydrophilic segment through the membrane
when multispanning membrane proteins are integrated into the
endoplasmic reticulum. We believe that the positioning of these two
regions in the membrane is appropriate and would be consistent with our
data when the whole picture of the AgrB membrane topology is
considered. Because both regions contain highly conserved positively
charged amino acid residues among all the AgrBs identified so far, we
hypothesized that the two hydrophilic transmembrane segments are
somehow contained in the four hydrophobic transmembrane segments, and
this configuration might be crucial for the processing and exporting of
AgrD peptide.
We provided direct evidence showing that AgrB is involved in the
proteolytic processing of AgrD. We could not exclude the possibility
that there may be other protein(s) associated with AgrB with the actual
enzymatic activity to carry out this reaction. The 9-kDa fragment
generated from AgrD propeptide in the presence of AgrB needs to be
further characterized to identify the precise cleavage site within
AgrD. The one or more active sites of AgrB involved in the proteolytic
processing of AgrD have not been identified. However, our preliminary
results showed that, although the mature AIP is secreted, the other
possible AgrD-processing products by AgrB and the AgrD propeptide were
membrane-bound, and these peptides were not found either in the cytosol
or in the culture supernatant.2 No AgrD-processing
intermediates were detected in the absence of AgrB (Fig. 3,
C and D). These results suggest that the AgrD proteolytic processing may occur within the membrane. It is also possible that this process may occur either in the cytosol or outside
of the cytoplasmic membrane, and the resulting processing products with
the exception of the mature AIP remain membrane-bound. It would be
ideal to utilize the agrB-phoA fusion constructs
we made to identify the possible AgrB active site(s) in E. coli. However, our attempts to generate functional mature
AIP from E. coli cells expressing wild-type AgrB
and AgrD were not successful so far. The reason for this is not clear.
We note that in Gram-positive bacteria that utilize peptide
autoinducers to activate the quorum sensing systems, such as in lactobacilli (42), streptococci (43), and Bacillus subtilis (44), the autoinducing peptides are processed and secreted by proteins
consisting of two domains, a proteolytic domain carrying out the
enzymatic reaction, and an ATP-binding domain forming an ATP-binding
cassette transporter that exports the mature autoinducing peptide (45,
46). These proteins are encoded by genes in the same operons as those
that encode propeptides and the two component signal transduction
systems. These operons have similar gene arrangement as that of the
agr P2 operon. We also note that AgrB is not homologous with
any of the known proteinases found in bacteria, and it does not have a
recognizable ATP binding motif. It is possible that S. aureus utilizes a different mechanism to generate an
autoinducer from those found in other Gram-positive bacteria. We
proposed the following hypothetical model for the processing of AgrD
propeptide and the secretion of the mature AIP in S. aureus: The propeptide is proteolytically cleaved at two
sites within AgrD by AgrB. Cleavage of the N-terminal peptide bond
could be a simple proteolytic cleavage. Processing at the C terminus
could involve cleavage of the C-terminal peptide bond resulting in a
peptide-enzyme acyl adduct, which would then undergo
trans-esterification with the cysteine thiol group. No external energy
(ATP) would be required for these reactions. It could be rapidly
followed by desolvation of the peptide concomitantly with its export,
and again there would not be any obligatory requirement for ATP.
Further study on the confirmation of the AgrB dual functions and the
identification of its functional domains will be required to define it
as a novel protein.
We thank Dr. Andrew Wright (Tufts University
School of Medicine) for kindly providing pAWLP-2 and pAWLP-3 plasmids
and rabbit polyclonal anti-E. coli PhoA antibody.
*
This work was supported by National Institutes of Health
Grant RO1AI46445 (to G. J.) and a USUHS grant (to G. J.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The amino acid sequences of these proteins can be accessed
through NCBI Protein Database under NCBI accession numbers CAA36781, AAB63264, AAB63267, AAG03055, AAC38295, and AAA71976.
¶
To whom correspondence should be addressed: Dept. of
Microbiology and Immunology, Uniformed Services University of the
Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814. Tel.:
301-295-9621; Fax: 301-295-1545; E-mail: gji@usuhs.mil.
Published, JBC Papers in Press, July 16, 2002, DOI 10.1074/jbc.M205367200
2
L. Zhang and G. Ji, unpublished result.
The abbreviations used are:
AIP, autoinducing
peptide;
agr, accessory gene regulator;
BlaZ,
Transmembrane Topology of AgrB, the Protein Involved in the
Post-translational Modification of AgrD in Staphylococcus
aureus*
,
,
¶
Department of Microbiology and Immunology,
Uniformed Services University of the Health Sciences, Bethesda,
Maryland 20814 and the § Molecular Pathogenesis
Program, Skirball Institute of Biomolecular Medicine, New York
University Medical Center, New York, New York 10016
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-lactamase promoter (PblaZ) was induced with 0.5 µg/ml
methicillin. Escherichia coli strain MC1061 (27) was grown
in LB broth and supplemented with tetracycline (20 µg/ml) when
necessary.
S. aureus plasmids and strains used in this study
agrB and the first three
codons of agrD was generated with oligonucleotides GJ#14
5'-GCTCTAGATCGTATAATGACAG-3' (before the Shine-Dalgarno
sequence of agrB, XbaI site, underlined), and GJ#15 5'-GTATTCATTTTAAGTCCTCC-3' (5' agrD,
italic) as primers, and pRN6911 as the template. This PCR product was
then digested with XbaI and ligated into the XbaI
and NdeI (blunted with Klenow) sites of
pRSET-A-agrD, resulting in the plasmid
pRSET-A-T7-6xhis-agrD. Finally, the
PCR product with oligonucleotides GJ#14 and GJ#13 as primers and
pRSET-A-T7-6xhis-agrD as the template
was prepared, digested with XbaI, and cloned into the
XbaI and EcoRI (blunted with Klenow) sites of
pRN5548. The resulting plasmid, pGJ4004, contains the coding sequence
for a bacterial phage T7 epitope and 6 histidine residues inserted at
the N terminus of AgrD. Both the N-terminal and the C-terminal
His6-tagged AgrD (AgrD-HDH) coding sequence was amplified
by PCR with the forward primer GJ#56 5'-GCTCTAGAAGCTATTACATTATTACC-3' (before the AgrD S.D.
sequence, XbaI underlined) and the reverse primer GJ#28
5'-CTAATGATGATGATGATGATGTTCGTGTAATTGTGTAATTC-3' (3' of
agrD, italic; 6 histidine codons and one stop codon,
underlined), and pGJ4004 as the template. This PCR product was digested
with XbaI and cloned into pRN5548 XbaI and
EcoRI (blunted with Klenow) sites to produce plasmid
pLZ4005. The sequences of all PCR products used above were confirmed by
DNA sequencing. Transformation of plasmid DNA were done by either the
protoplast method (26) or electroporation (28).
80 °C. Protein
concentration was measured with a detergent-compatible protein assay
kit (Bio-Rad). E. coli MC1061 cells containing the
phoA expression vector or agrB-phoA
fusion plasmid were grown in LB broth overnight at 37 °C with
shaking. After centrifugation, cell pellets were lysed by brief
sonication in buffer consisting of 1% Triton X-100, 25% sucrose, 1 mM EDTA, 1 mg/ml lysozyme, and 1 mM
phenylmethanesulfonyl fluoride. The Triton X-100-insoluble fraction of
the whole cell lysate was prepared by ultracentrifugation at
200,000 × g for 2 h at 4 °C. The pellets were
dissolved in 1 × SDS sample buffer (27), boiled for 5 min, and
stored at
20 °C.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-helices were slightly different for some AgrBs. A total of five
possible transmembrane segments were predicted from these analyses.

View larger version (37K):
[in a new window]
Fig. 1.
AgrB-PhoA fusion analyses. A,
Western blot of Triton X-100-insoluble fractions from
overnight cultures of E. coli MC1061 carrying
cloning vector pAWLP-2 (A2), or pAWLP-3
(A3), or agrB-phoA fusion plasmids (as
named by the fusion points within AgrB). The positions of the molecular
weight markers are indicated to the left by
arrows. B, alkaline phosphatase (PhoA) activities
of overnight cultures of E. coli MC1061 cells
expressing different AgrB-PhoA fusions. Values are means from three
independent experiments with standard errors as indicated.

View larger version (30K):
[in a new window]
Fig. 2.
Transmembrane topology of AgrB.
A, hydropathy profiles of AgrBs. The AgrB sequences from all
four reported groups of S. aureus (Sa I, NCBI
accession number CAA36781; Sa II, NCBI accession number
AAB63264; Sa III, NCBI accession number AAB63267; and
Sa IV, NCBI accession number AAG03055) and that of S. epidermidis (Se, NCBI accession number AAC38295) and
S. lugdunensis (Sl, NCBI accession number
AAA71976) were analyzed by the method of Kyte and Doolittle (32) using
a window of 9. The hydrophobicity plots predicted from TopPred 2, TMHMM, and DAS are similar. The predicted five putative transmembrane
-helices (I-V) are indicated. B, proposed transmembrane
topology of AgrB. S. aureus RN6390B (group I)
AgrB is shown. Location of the AgrB-PhoA fusion points are indicated:
triangle, high PhoA activities; rectangle, low
PhoA activities. The predicted transmembrane
-helices by TopPred II,
TMHMM, and DAS analyses are indicated by filled
shapes.

View larger version (28K):
[in a new window]
Fig. 3.
Involvement of AgrB in the proteolytic
processing of AgrD. A, a schematic diagram of AgrD-HDH.
The tags and the possible AgrD-processing products are indicated
(A-F), and their predicted molecular weights are also
shown. B, AIP activities produced by AgrB- and
AgrD-expressing strains. Values are means from three independent
experiments with standard errors as indicated. Western blots of whole
cell lysates from strains with either anti-pentaHis monoclonal antibody
(C) or anti-T7 tag monoclonal antibody (D). For
both C and D, lane 1, LZ0001;
lane 2, LZ4005; lane 3, LZ0403; lane
4, LZ2403. In each lane, 7.5 µg of total protein was loaded. The
sizes, determined by the positions of molecular weight markers, are
shown on the left side by arrows. A weak band in
both C and D, lane 4, is indicated by
an arrow to the right side.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
-lactamase;
PblaZ, blaZ promoter;
PhoA, alkaline phosphatase;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine;
DAS, Dense Alignment Surface.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Projan, S. J.,
and Novick, R. P.
(1997)
in
The Staphylococci in Human Disease
(Crossley, K. B.
, and Archer, G. L., eds)
, pp. 55-81, Churchill Livingstone, New York
2.
Ji, G.,
Beavis, R.,
and Novick, R. P.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
12055-12059 3.
Ji, G.,
Beavis, R.,
and Novick, R. P.
(1997)
Science
276,
2027-2030 4.
Novick, R. P.
(1999)
in
Cell-Cell Signaling in Bacteria
(Dunny, G. M.
, and Winans, S. C., eds)
, pp. 129-146, American Society for Microbiology, Washington, D. C.
5.
Novick, R. P.
(2000)
in
Gram-Positive Pathogens
(Fischetti, V. A.
, Novick, R. P.
, Ferretti, J. J.
, Portnoy, D. A.
, and Rood, J. I., eds)
, pp. 392-407, American Society for Microbiology, Washington, D. C.
6.
Janzon, L.,
and Arvidson, S.
(1990)
EMBO J.
9,
1391-1399[Medline]
[Order article via Infotrieve]
7.
Novick, R. P.,
Projan, S. J.,
Kornblum, J.,
Ross, H. F., Ji, G.,
Kreiswirth, B.,
Vandenesch, F.,
and Moghazeh, S.
(1995)
Mol. Gen. Genet.
248,
446-458[CrossRef][Medline]
[Order article via Infotrieve]
8.
Novick, R. P.,
Ross, H. F.,
Projan, S. J.,
Kornblum, J.,
Kreiswirth, B.,
and Moghazeh, S.
(1993)
EMBO J.
12,
3967-3975[Medline]
[Order article via Infotrieve]
9.
Zhang, S.,
and Stewart, G. C.
(2000)
J. Bacteriol.
182,
2321-2325 10.
Chan, P. F.,
and Foster, S. J.
(1998)
Microbiology
144,
2469-2479[Abstract]
11.
Benito, Y.,
Kolb, F. A.,
Romby, P.,
Lina, G.,
Etienne, J.,
and Vandenesch, F.
(2000)
RNA (N. Y.)
6,
668-679
12.
Tegmark, K.,
Morfeldt, E.,
and Arvidson, S.
(1998)
J. Bacteriol.
180,
3181-3186[Abstract]
13.
Lina, G.,
Jarraud, S., Ji, G.,
Greenland, T.,
Pedraza, A.,
Etienne, J.,
Novick, R. P.,
and Vandenesch, F.
(1998)
Mol. Microbiol.
28,
655-662[CrossRef][Medline]
[Order article via Infotrieve]
14.
Lyon, G. J.,
Wright, J.,
Christopoulos, A.,
Novick, R. P.,
and Muir, T. W.
(2002)
J. Biol. Chem.
277,
6247-6253 15.
Peng, H. L.,
Novick, R. P.,
Kreiswirth, B.,
Kornblum, J.,
and Schlievert, P.
(1988)
J. Bacteriol.
170,
4365-6372 16.
Morfeldt, E.,
Panova-Sapundjieva, I.,
Gustafsson, B.,
and Arvidson, S.
(1996)
FEMS Microbiol. Lett.
143,
195-201[CrossRef][Medline]
[Order article via Infotrieve]
17.
Morfeldt, E.,
Tegmark, K.,
and Arvidson, S.
(1996)
Mol. Microbiol.
21,
1227-1237[CrossRef][Medline]
[Order article via Infotrieve]
18.
Cheung, A. L.,
and Projan, S. J.
(1994)
J. Bacteriol.
176,
4168-4172 19.
Cheung, A. L.,
Bayer, M. G.,
and Heinrichs, J. H.
(1997)
J. Bacteriol.
179,
3963-3971 20.
Novick, R. P.,
and Muir, T. W.
(1999)
Curr. Opin. Microbiol.
2,
40-45[CrossRef][Medline]
[Order article via Infotrieve]
21.
Otto, M.,
Sussmuth, R.,
Jung, G.,
and Gotz, F.
(1998)
FEBS Lett.
424,
89-94[CrossRef][Medline]
[Order article via Infotrieve]
22.
Mayville, P., Ji, G.,
Beavis, R.,
Yang, H.,
Goger, M.,
Novick, R. P.,
and Muir, T. W.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
1218-1223 23.
Jarraud, S.,
Lyon, G. J.,
Figueiredo, A. M.,
Gerard, L.,
Vandenesch, F.,
Etienne, J.,
Muir, T. W.,
and Novick, R. P.
(2000)
J. Bacteriol.
182,
6517-6522 24.
Mdowell, P.,
Affas, Z.,
Reynolds, C.,
Holden, M. T.,
Wood, S. J.,
Saint, S.,
Cockayne, A.,
Hill, P. J.,
Dodd, C. E.,
Bycroft, B. W.,
Chan, W. C.,
and Williams, P.
(2001)
Mol. Microbiol.
41,
503-512[CrossRef][Medline]
[Order article via Infotrieve]
25.
Saenz, H. L.,
Augsburger, V.,
Vuong, C.,
Jack, R. W.,
Gotz, F.,
and Otto, M.
(2000)
Arch. Microbiol.
174,
452-455[CrossRef][Medline]
[Order article via Infotrieve]
26.
Novick, R. P.
(1991)
Methods Enzymol.
204,
587-636[Medline]
[Order article via Infotrieve]
27.
Sambrook, J.,
and Russell, D. W.
(2001)
Molecular Cloning: A Laboratory Manual
, 3rd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
28.
Schenk, S.,
and Laddaga, R. A.
(1992)
FEMS Microbiol. Lett.
73,
133-138[Medline]
[Order article via Infotrieve]
29.
Hoffman, C. S.,
and Wright, A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
5107-5111 30.
Schagger, H.,
and von Jagow, G.
(1987)
Anal. Biochem.
166,
368-379[CrossRef][Medline]
[Order article via Infotrieve]
31.
Vandenesch, F.,
Projan, S. J.,
Kreiswirth, B.,
Etienne, J.,
and Novick, R. P.
(1993)
FEMS Microbiol. Lett.
111,
115-122[CrossRef][Medline]
[Order article via Infotrieve]
32.
Kyte, J.,
and Doolittle, F. R.
(1982)
J. Mol. Biol.
157,
105-132[CrossRef][Medline]
[Order article via Infotrieve]
33.
von Heijne, G.
(1992)
J. Mol. Biol.
225,
487-494[CrossRef][Medline]
[Order article via Infotrieve]
34.
Krogh, A.,
Larsson, B.,
von Heijne, G.,
and Sonnhammer, E. L.
(2001)
J. Mol. Biol.
305,
567-580[CrossRef][Medline]
[Order article via Infotrieve]
35.
Cserzo, M.,
Wallin, E.,
Simon, I.,
von Heijne, G.,
and Elofsson, A.
(1997)
Protein Eng.
10,
673-676 36.
Lyon, G. J.,
Mayville, P.,
Muir, T. W.,
and Novick, R. P.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
13330-13335 37.
Franke, C. M.,
Tiemersma, J.,
Venema, G.,
and Kok, J.
(1999)
J. Biol. Chem.
274,
8484-8490 38.
Ginn, S. L.,
Brown, M. H.,
and Skurray, R. A.
(1997)
J. Bacteriol.
179,
3786-3789 39.
Paulsen, I. T.,
Brown, M. H.,
Littlejohn, T. G.,
Mitchell, B. A.,
and Skurray, R. A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3630-3635 40.
Calamia, J.,
and Manoil, C.
(1992)
J. Mol. Biol.
224,
539-543[CrossRef][Medline]
[Order article via Infotrieve]
41.
Ota, K.,
Sakaguchi, M.,
von Heijne, G.,
Hamasaki, N.,
and Mihara, K.
(1998)
Mol. Cell
2,
495-503[CrossRef][Medline]
[Order article via Infotrieve]
42.
Brurberg, M. B.,
Nes, I. F.,
and Eijsink, V. G.
(1997)
Mol. Microbiol.
26,
347-360[CrossRef][Medline]
[Order article via Infotrieve]
43.
Pestova, E. V.,
Havarstein, L. S.,
and Morrison, D. A.
(1996)
Mol. Microbiol.
21,
853-862[CrossRef][Medline]
[Order article via Infotrieve]
44.
Magnuson, R.,
Solomon, J.,
and Grossman, A. D.
(1994)
Cell
77,
207-216[CrossRef][Medline]
[Order article via Infotrieve]
45.
Havarstein, L. S.,
Diep, D. B.,
and Nes, I. F.
(1995)
Mol. Microbiol.
16,
229-240[Medline]
[Order article via Infotrieve]
46.
Kleerebezem, M.,
Quadri, L. E.,
Kuipers, O. P.,
and de Vos, W. M.
(1997)
Mol. Microbiol.
24,
895-904[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. J. H. Goldsworthy Gene expression of Pseudomonas aeruginosa and MRSA within a catheter-associated urinary tract infection biofilm model Bioscience Horizons, March 1, 2008; 1(1): 28 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Hsieh, C. W. Tseng, and G. C. Stewart Regulation of Rot Expression in Staphylococcus aureus J. Bacteriol., January 15, 2008; 190(2): 546 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Shaw, I.-M. Jonsson, V. K. Singh, A. Tarkowski, and G. C. Stewart Inactivation of traP Has No Effect on the Agr Quorum-Sensing System or Virulence of Staphylococcus aureus Infect. Immun., September 1, 2007; 75(9): 4519 - 4527. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nakayama, S. Chen, N. Oyama, K. Nishiguchi, E. A. Azab, E. Tanaka, R. Kariyama, and K. Sonomoto Revised Model for Enterococcus faecalis fsr Quorum-Sensing System: the Small Open Reading Frame fsrD Encodes the Gelatinase Biosynthesis-Activating Pheromone Propeptide Corresponding to Staphylococcal AgrD J. Bacteriol., December 1, 2006; 188(23): 8321 - 8326. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Liang, C. Yu, J. Sun, H. Liu, C. Landwehr, D. Holmes, and Y. Ji Inactivation of a Two-Component Signal Transduction System, SaeRS, Eliminates Adherence and Attenuates Virulence of Staphylococcus aureus. Infect. Immun., August 1, 2006; 74(8): 4655 - 4665. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Scott, J. C. Martin, G. Campbell, C.-D. Mayer, and H. J. Flint Whole-Genome Transcription Profiling Reveals Genes Up-Regulated by Growth on Fucose in the Human Gut Bacterium "Roseburia inulinivorans". J. Bacteriol., June 1, 2006; 188(12): 4340 - 4349. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. J. Sturme, J. Nakayama, D. Molenaar, Y. Murakami, R. Kunugi, T. Fujii, E. E. Vaughan, M. Kleerebezem, and W. M. de Vos An agr-Like Two-Component Regulatory System in Lactobacillus plantarum Is Involved in Production of a Novel Cyclic Peptide and Regulation of Adherence J. Bacteriol., August 1, 2005; 187(15): 5224 - 5235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Tseng and G. C. Stewart Rot Repression of Enterotoxin B Expression in Staphylococcus aureus J. Bacteriol., August 1, 2005; 187(15): 5301 - 5309. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Harraghy, J. Kormanec, C. Wolz, D. Homerova, C. Goerke, K. Ohlsen, S. Qazi, P. Hill, and M. Herrmann sae is essential for expression of the staphylococcal adhesins Eap and Emp Microbiology, June 1, 2005; 151(6): 1789 - 1800. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ji, W. Pei, L. Zhang, R. Qiu, J. Lin, Y. Benito, G. Lina, and R. P. Novick Staphylococcus intermedius Produces a Functional agr Autoinducing Peptide Containing a Cyclic Lactone J. Bacteriol., May 1, 2005; 187(9): 3139 - 3150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Qiu, W. Pei, L. Zhang, J. Lin, and G. Ji Identification of the Putative Staphylococcal AgrB Catalytic Residues Involving the Proteolytic Cleavage of AgrD to Generate Autoinducing Peptide J. Biol. Chem., April 29, 2005; 280(17): 16695 - 16704. [Abstract] [Full Text] [PDF] |
||||